Binit Kumar: Email & Phone Number

Work Experience 21 years

Associate Director, Toxicology at Pharmaron

Jan 2024 - Current

Director, Pharmacology & Biomarkers at PTC Therapeutics, Inc.

Jan 2023 - Jan 2024

Associate Director, Pharmacology & Biomarkers/Gene Therapy at PTC Therapeutics, Inc.

Jan 2021 - Jan 2023

Principal Scientist, Pharmacology/Gene Therapy at PTC Therapeutics, Inc.

Jan 2019 - Jan 2021

Scientist II, Pharmacology/Biological Development (Gene Editing) at Editas Medicine

Jan 2018 - Jan 2019

Research Associate at Tufts University School of Medicine

Jan 2018 - Jan 2018

Post Doctoral Fellow at Tufts University School of Medicine

Jan 2015 - Jan 2018

Postdoctoral Fellow at Wayne State University

Jan 2013 - Jan 2015

Senior Research Fellow (Department of Science & Technology,Govt. Of India, India) at Delhi University

Jan 2009 - Jan 2013

RESEARCH OFFICER at Fortis Clinical Research Ltd.

Jan 2008 - Jan 2009

Research Scholar at Delhi University

Jan 2006 - Jan 2008

Analyst at Fortis Clinical Research Ltd.

Jan 2005 - Jan 2006

Binit is proficient in English and Hindi. Their professional focus is AAV, ADENO ASSOCIATED VIRUS (AAV), and Animal Models across 3 core areas.

Binit holds Diplomate of the American Board of Toxicology certifications and has registered patents, including "Methods of inhibiting inflammasome activation (CD59 Gene Therapy), Regulation of transgene expression using a small molecule inducible splicing switch, and A synergistic composition for prevention and treatment of diabetic retinopathy and cataract". They have also been awarded ARVO-International Travel Grant Award for presenting scientific paper at 2013 ARVO Annual Meeting, May 5-9, Seattle, Washington, USA as Young Investigator., International Travel Support Grant as Young Scientist for presenting scientific paper at APAO 2011, Sydney, Australia, and Best Poster Award at International Symposium on “Advances in Pharmacotherapy of Cardiovascular Diseases